Acute Lymphoblastic Leukemia Annotated Bibliography

Verified

Added on  2020/04/21

|4
|823
|186
AI Summary
This annotated bibliography examines five scholarly articles related to Acute Lymphoblastic Leukemia (ALL). The articles delve into genetic susceptibility factors, the effectiveness of CAR T-cell therapy, the role of specific genes in ALL development, collaborative advancements in understanding and treating the disease, and the identification of novel disease subtypes. The bibliography provides a comprehensive overview of current research and insights into this childhood cancer.
tabler-icon-diamond-filled.svg

Contribute Materials

Your contribution can guide someone’s learning journey. Share your documents today.
Document Page
Running head: ACUTE LYMPHOCYTIC LEUKEMIA 1
Annotated bibliography on Acute Lymphocytic Leukemia (ALL)
Frederick Wilson
Columbia Southern University
tabler-icon-diamond-filled.svg

Secure Best Marks with AI Grader

Need help grading? Try our AI Grader for instant feedback on your assignments.
Document Page
ACUTE LYMPHOCYTIC LEUKEMIA 2
Akin, D. F., Oner, D. A., Sipahi, K., Mumcuoglu, M., Kurekci, E., Ezer, U., & Akar, N. (2017).
Screening of polymorphisms in the folate pathway in Turkish pediatric Acute
Lymphoblastic Leukemia patients. Egyptian Journal of Medical Human Genetics, 18(4),
p349-353. 5p.
The authors investigated polymorphisms of folate related genes that increase the
susceptibility to childhood ALL. Genotyping, RFLP AND RT-PCT screened 5
polymorphisms. The article was chosen as it showed an association between TYMS
1494del6 and ALL and demonstrated lack of association with DHFR, MTHFR and CBS
genes.
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., ... & Qu, J. (2014).
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute
lymphoblastic leukemia. Science translational medicine, 6(224), 224ra25-224ra25.
The authors aimed to assess the effectiveness of autologous T cells that expressed 19-28z
chimeric antigen receptor on ALL. It identified the diagnostic criteria for severe cytokine
release syndrome and found serum C-reactive proteins to be reliable indicators. This
article was chosen as it provided strong evidence for conduction of T-cell therapy.
Inaba, H., Greaves, M., & Mullighan, C. G. (2013). Acute lymphoblastic leukaemia. The
Lancet, 381(9881), 1943-1955.
This article helped in the identification of the multifactorial causation, genetic
susceptibility and exposure rates that increase the likelihood of a person becoming
affected with ALL. The study was chosen as it identified novel structural mutations and
genetic changes through genome wide profiling and also helped in defining new disease
subtypes and treatment response.
Document Page
ACUTE LYMPHOCYTIC LEUKEMIA 3
Jayaraman, A., & Jamil, K. (2012). Clusters of CDK2, CCND1, and CMYC genes involved in
cancers: Acute Lymphocytic Leukemia (ALL) as a model. Biology and Medicine, 4(1),
37.
The study analysed the cell cycles and role of the CCND1, CKD2 and C-MYC genes on
ALL in children. A thorough search of literature databases, sequencing of DNA and
phylogenetic tree construction was done. The article was chosen as it helped in
determining loss of functions in the genes during the course of evolution.
Pui, C. H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., ... & Escherich, G.
(2015). Childhood acute lymphoblastic leukemia: progress through collaboration. Journal
of Clinical Oncology, 33(27), 2938-2948.
The authors evaluated the impact of collaborative studies that would help in providing a
clear understanding of the advances in the physiology and treatment of the disease in
children and adolescents. This article adds to the chosen topic since it provided
information on ALL heterogeneity that could be used to improve personalized treatment
and quality of life.
Document Page
ACUTE LYMPHOCYTIC LEUKEMIA 4
References
Akin, D. F., Oner, D. A., Sipahi, K., Mumcuoglu, M., Kurekci, E., Ezer, U., & Akar, N. (2017).
Screening of polymorphisms in the folate pathway in Turkish pediatric Acute
Lymphoblastic Leukemia patients. Egyptian Journal of Medical Human Genetics, 18(4),
p349-353. 5p.
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., ... & Qu, J. (2014).
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute
lymphoblastic leukemia. Science translational medicine, 6(224), 224ra25-224ra25.
Inaba, H., Greaves, M., & Mullighan, C. G. (2013). Acute lymphoblastic leukaemia. The
Lancet, 381(9881), 1943-1955.
Jayaraman, A., & Jamil, K. (2012). Clusters of CDK2, CCND1, and CMYC genes involved in
cancers: Acute Lymphocytic Leukemia (ALL) as a model. Biology and Medicine, 4(1),
37.
Pui, C. H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., ... & Escherich, G.
(2015). Childhood acute lymphoblastic leukemia: progress through collaboration. Journal
of Clinical Oncology, 33(27), 2938-2948.
chevron_up_icon
1 out of 4
circle_padding
hide_on_mobile
zoom_out_icon
[object Object]

Your All-in-One AI-Powered Toolkit for Academic Success.

Available 24*7 on WhatsApp / Email

[object Object]